✦ LIBER ✦

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

✍ Scribed by Nurşen Düzgün; Ergin Ayaşlioğlu; Hüseyin Tutkak; Olcay T. Aydintuğ

Book ID: 106006769
Publisher: Springer
Year: 2003
Tongue: English
Weight: 195 KB
Volume: 25
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-003-0400-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of tumor necrosis factor-α, int

Analysis of tumor necrosis factor-α, interleukin-6, interleukin-1β, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders

✍ Keiseki Kaneyama; Natsuki Segami; Wei Sun; Jun Sato; Kazuma Fujimura 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Induction of circulating soluble tumour

Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1α infusion in humans

✍ Herbert Tilg; Elizabeth Trehu; Leland Shapiro; Dietrich Pape; Michael B. Atkins; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Combination benefit of treatment with th

Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis

✍ Alison M. Bendele; Elizabeth S. Chlipala; Jon Scherrer; Janet Frazier; Gina Senn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Objective. To determine the potential for additive or synergistic effects of combination therapy with the recombinant anticytokine agents interleukin-1 receptor antagonist (IL-1Ra) and PEGylated soluble tumor necrosis factor receptor type I (PEG sTNFRI) in established type II collagen-induced arthri

Influence of hypercortisolemia on solubl

Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings

✍ Annabel E. Barber; Susette M. Coyle; Eva Fischer; Christopher Smith; Tom van der 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Effects of interferon-α2a treatment on s

Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease

✍ A. Kosar; S. Haznedaroglu; Y. Karaaslan; Y. Büyükasik; I. C. Haznedaroglu; D. Öz 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 73 KB

Soluble tumor necrosis factor receptor-1

Soluble tumor necrosis factor receptor-1 in preterm infants with chronic lung disease

✍ Miho Sato; Masaaki Mori; Shigeru Nishimaki; Hiromi An; Takuya Naruto; Toshiyuki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB